TOBI (tobramycin inhalation solution) Patient Assistance Program
Don’t let the high cost of brand specialty inhaled antibiotic therapy disrupt your cystic fibrosis treatment. We help eligible patients access TOBI (tobramycin inhalation solution) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- TOBI (tobramycin inhalation solution 300 mg/5 mL) is FDA-approved for the management of cystic fibrosis (CF) patients ≥6 years with Pseudomonas aeruginosa airway colonization. It is delivered via PARI LC PLUS nebulizer in 28-day on/28-day off cycles. TOBI Podhaler is a dry-powder inhaler alternative.
- Without assistance, brand TOBI costs commonly run approximately $5,500–$7,500 per 28-day on cycle.
- Through AffordMyPrescriptions, qualifying patients can access TOBI for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic tobramycin inhalation solution is widely available at substantially lower cost — often $1,500–$3,000 per cycle. Other inhaled anti-pseudomonal antibiotics for chronic CF airway colonization include aztreonam for inhalation solution (Cayston, also brand) and inhaled colistin (compounded). Many CF centers alternate TOBI cycles with Cayston cycles for year-round suppression.
What Is TOBI Prescription Assistance Program?
The TOBI Prescription Assistance Program is a manufacturer-sponsored initiative that provides TOBI at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for CF patients with Pseudomonas airway colonization who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, CF center coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment.
Pharmacy Price Comparison
- Without assistance, brand TOBI costs roughly $5,500–$7,500 per cycle. Generic tobramycin inhalation solution is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$7,200/cycle | Save substantially |
| CVS Pharmacy (brand) | ~$7,500/cycle | Save substantially |
| Walmart (brand) | ~$5,800/cycle | Save substantially |
| Costco (brand) | ~$5,600/cycle | Save substantially |
Generic tobramycin inh | ~$2,000/cycle | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your TOBI Prescription Program?
The Patient Assistance Program is free to apply for and provides TOBI at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic tobramycin inhalation solution widely available at substantially lower cost, generic is usually the cheaper path for most patients.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for TOBI:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $5,500–$7,500/cycle per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for TOBI assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid TOBI Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding TOBI:
TOBI (tobramycin inhalation solution) is an inhaled aminoglycoside antibiotic used to chronically suppress Pseudomonas aeruginosa in CF airways. It delivers high local antibiotic concentrations to the airways without significant systemic toxicity. Used in 28-day on / 28-day off cycles to maintain Pseudomonas suppression while limiting resistance pressure.
How TOBI Works:
Most adults and adolescents with cystic fibrosis experience chronic airway colonization by Pseudomonas aeruginosa, which drives progressive lung damage and ongoing inflammation. Tobramycin is an aminoglycoside antibiotic that combats this by binding to the bacterial 30S ribosomal subunit and inhibiting protein synthesis. Administering it via inhalation delivers high antibiotic concentrations directly to airway secretions while avoiding systemic side effects like kidney or ear toxicity. To limit bacterial resistance, the treatment follows a 28-day on/off cycle, and many cystic fibrosis centers alternate it with other inhaled antibiotics for year-round suppression.
Form and use:
The standard liquid formulation of TOBI is administered as a 300 mg dose via a compatible nebulizer twice daily for a 28-day period, followed by 28 days off. Each nebulization session takes roughly 15 minutes, and patients should use a bronchodilator beforehand to maximize lung deposition. Alternatively, the TOBI Podhaler offers a dry-powder option where patients inhale the contents of four capsules twice daily for faster administration.
Generic availability:
Generic versions of the tobramycin inhalation solution are widely available in the United States at a substantially lower cost than brand-name TOBI. However, the dry-powder TOBI Podhaler remains brand-only, as does Cayston, another common inhaled anti-pseudomonal antibiotic. Patients may also utilize compounded inhaled colistin, and many cystic fibrosis centers alternate between generic tobramycin and Cayston during their treatment cycles.
Warnings:
TOBI carries warnings for ototoxicity, which can cause hearing loss, tinnitus, or vertigo, making periodic audiometry monitoring highly recommended. While nephrotoxicity is rare with the inhaled route, kidney function should still be monitored periodically. The medication must be used with caution in patients with neuromuscular disorders like Parkinson’s disease or myasthenia gravis, and it should be avoided during pregnancy due to embryo-fetal toxicity risks. Finally, to prevent bronchospasm, patients should use a bronchodilator before their dose and have their lung function monitored.
FAQ (Frequently Asked Questions)
How Much Does TOBI Cost Without Insurance?
Brand TOBI costs approximately $5,500–$7,500 per 28-day cycle. Generic tobramycin inhalation solution is dramatically cheaper. Through AffordMyPrescriptions, qualifying patients receive TOBI at no medication cost — our $69.95 monthly fee covers full advocacy and program management. Most patients find generic tobramycin inhalation solution is the cheaper path.
Is Generic Tobramycin Inhalation Solution The Same As Brand TOBI?
Yes. The FDA approves generic tobramycin inhalation solution as bioequivalent to brand TOBI. Most CF centers and insurance plans prefer generic.
Why The 28-Day On / 28-Day Off Schedule?
The original TOBI clinical trials used 28 days on / 28 days off cycling — this regimen reduces continuous antibiotic exposure (limiting resistance pressure) while providing year-round Pseudomonas suppression when alternated with another inhaled antibiotic (typically Cayston aztreonam) during the 28-day off period. Many CF centers do continuous suppression with this alternating regimen — TOBI for 28 days, Cayston for 28 days, repeat.
How Is TOBI Different From Cayston?
Both are inhaled anti-pseudomonal antibiotics for chronic CF airway colonization. TOBI (tobramycin, aminoglycoside) — twice daily for 28 days; generic available. Cayston (aztreonam, monobactam) — three times daily for 28 days; brand only (uses Altera Nebulizer). Many CF centers alternate the two for year-round suppression. Cycling between different antibiotic classes also reduces resistance pressure.
What About TOBI Podhaler?
TOBI Podhaler is a dry-powder formulation of tobramycin — inhaled via a handheld device instead of nebulization. Faster (a few minutes vs. ~15 min) and more portable than the nebulized form. However, may cause more cough and bronchospasm than the nebulized form for some patients. TOBI Podhaler remains brand only. Discuss with your CF team if convenience is important.
What Monitoring Do I Need?
Periodic audiometry (hearing test) — aminoglycosides can cause cumulative ototoxicity; check at baseline and approximately annually. Renal function (creatinine) periodically — though systemic absorption from inhalation is low. Lung function (FEV1) regularly. Sputum culture/sensitivity periodically to monitor for resistance development.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic tobramycin inhalation solution (much cheaper), Cayston (aztreonam inhalation), the manufacturer’s copay program for commercially insured patients, the Cystic Fibrosis Foundation Compass program (for CF patients), or independent foundations such as the CF Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of TOBI, our team may be able to help you access assistance programs — or guide you to generic tobramycin inhalation solution. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.